Form 8-K - Current report:
SEC Accession No. 0001070081-20-000094
Filing Date
2020-04-30
Accepted
2020-04-30 16:04:54
Documents
16
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k43020q1.htm   iXBRL 8-K 42189
2 EXHIBIT 99.1 ptct2020q1earningsrele.htm EX-99.1 125536
8 ptct2020q1_image1a01.gif GRAPHIC 6607
  Complete submission text file 0001070081-20-000094.txt   335963

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200430.xsd EX-101.SCH 4701
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200430_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200430_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200430_lab.xml EX-101.LAB 26468
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200430_pre.xml EX-101.PRE 13685
14 EXTRACTED XBRL INSTANCE DOCUMENT a8k43020q1_htm.xml XML 4407
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 20835601
SIC: 2834 Pharmaceutical Preparations